Business
SANUWAVE Health Announces Exclusive Licensing of NanoVibronix, Inc. Surface Acoustic Wave Ultrasound Technology
SUWANEE, GA, April 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) and NanoVibronix, Inc. have announced an exclusive
About this update from Sanuwave Health, Inc.
[{"type":"text","content":"SUWANEE, GA, April 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) and NanoVibronix, Inc. have announced an exclusive worldwide license agreement for NanoVibronix’s surface acoustic wave ultrasound technology in the wound care market. \n Under this agreement, SANUWAVE has acquired the exclusive worldwide license and sales rights for NanoVibronix’s patch-based therapeutic ultrasound technology device, WoundShield®, that facilitates tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. SANUWAVE will seek regulatory approval of WoundShield® in Europe and the United States and NanoVibronix shall maintain the sole right to manufacture the licensed products. Commenting on the agreement, Kevin A. Richardson II, Chairman of the Board and CEO of SANUWAVE, said, \"It is one of those great partnerships where our organization offers strong commercialization and sales capabilities and a complementary energy-based wound care treatment system in the dermaPACE® System. NanoVibronix's expertise in surface acoustic wave ultrasound technology development is unmatched and we are very happy to have the responsibility to grow a high-quality product that has key benefits.\" Brian Murphy, Chief executive Officer of NanoVibronix, added, \"By leveraging the strength of SANUWAVE's commercial organization, we're able to focus on continued innovation in the surface acoustic wave ultrasound technology area. Together, I am hopeful that we can offer wound care professionals another high quality, treatment modality that can be applied to diabetic foot ulcers in between dermaPACE® System treatments. We look forward to working with SANUWAVE now and in the future.\" About SANUWAVE Health, Inc. SANUWAVE Health, Inc. (OTCQB: SNWV) is a shockwave technology company initially focused on the development and commercialization of patented noninvasive, biological response activating devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures. SANUWAVE’s portfolio of regenerative medicine products and product candidates activate biologic signaling and angiogenic responses, producing new vascularization and microcirculatory improvement, which helps restore the body’s normal healing processes and regeneration. SANUWAVE applies its patente...